Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ·Healthcare·Biotechnology
$29.27
-0.80%
Mkt Cap $3.62B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (28 analysts)
$52.20
Range $42.00 – $57.00
Implied Upside
+78.3%
Consensus $52.20 vs current $29.27
NASDAQ·Healthcare·Biotechnology
$29.27
-0.80%
Mkt Cap $3.62B
Buy
10
Hold
0
Sell
0
Price Target (28 analysts)
$52.20
Range $42.00 – $57.00
+78.3%
Consensus $52.20 vs current $29.27